logo
Select company
Select metric
Ticker Information

Ticker

AARD

Company Name

AARDVARK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AARDVARK THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AARD - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
12/31/2024$ 332K
12/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AARDVARK THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, AARDVARK THERAPEUTICS INC's average CF - Equity has been $ 166K.
  • The median CF - Equity for AARDVARK THERAPEUTICS INC during this period was $ 166K
  • AARDVARK THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 332K.
  • The lowest CF - Equity recorded by AARDVARK THERAPEUTICS INC in the same timeframe $ 0

AARDVARK THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
GALT : GALECTIN THERAPEUTICS INC $ 2.79MJBIO : JADE BIOSCIENCES INC $ 191.18MFENC : FENNEC PHARMACEUTICALS INC $ 0OABI : OMNIAB INC $ 12.82MVNDA : VANDA PHARMACEUTICALS INC $ 0ALLO : ALLOGENE THERAPEUTICS INC $ 18.58MLCTX : LINEAGE CELL THERAPEUTICS INC $ 27.02MNMRA : NEUMORA THERAPEUTICS INC $ 17.16MFDMT : 4D MOLECULAR THERAPEUTICS INC $ 2.03MLXEO : LEXEO THERAPEUTICS INC $ 73.31M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

AARD - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2023

$ 332K

Maximum

Dec 31, 2024

$ 166K

Average

$ 166K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M